The BinaxNOW® Legionella test, available from Inverness Medical provides significant time saving advantages over traditional sputum culture. Providing results in fifteen minutes from urine samples, BinaxNOW Legionella enables...
More than one quarter (26%) of primary care patients 40 years of age and older with a smoking history and symptoms of chronic bronchitis had airflow obstruction consistent with a diagnosis of COPD PHILADELPHIA, October 28, 2008...
GlaxoSmithKline (NYSE: GSK) announced findings from a cross-sectional study which showed that 26 percent of primary care patients 40 years of age and older with a history of smoking and symptoms of chronic bronchitis actually...
Posted on: Tuesday, 28 October 2008, 15:00 CDT PHILADELPHIA, Oct. 28 /PRNewswire-FirstCall/ -- GlaxoSmithKline today announced findings from a cross-sectional study which showed that 26 percent of primary care patients 40 years...
Tuesday October 28, 1:30 pm ET - More than one quarter (26%) of primary care patients 40 years of age and older with a smoking history and symptoms of chronic bronchitis had airflow obstruction consistent with a diagnosis of...
PHILADELPHIA, Oct. 28 /PRNewswire-FirstCall/ -- GlaxoSmithKline today announced findings from a cross-sectional study which showed that 26 percent of primary care patients 40 years of age and older with a history of smoking and...
There are many types and causes of cough. Being able to identify the types of cough may help you determine when to seek medical help. Everyone has experienced a serious bout of coughing at least once in their lives, and the...
The BinaxNOW® Legionella test, available from Inverness Medical, provides significant time-saving advantages over traditional sputum culture. Providing results in 15 minutes from urine samples, BinaxNOW Legionella enables the...
Regenerx Biopharmaceuticals, INC. (AMEX:RGN) announced today that it is seeking a strategic partner to assist in the development of RGN-457 for the treatment of cystic fibrosis (CF). RGN-457 is based on thymosin beta 4 (Tβ4)...
Mpex Pharmaceuticals, Inc. announced additional clinical and preclinical results with MP-376, the company's novel formulation of levofloxacin inhaled solution delivered by an Investigational eFlow Nebulizer System for use in...